Current Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2021 - Present
Medicine, Medical Oncology,
Medicine
Recent Publications
Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates
Journal Article Clinical Genitourinary Cancer · February 1, 2026 Background Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging is highly sensitive, enabling detection of disease not visualized on conventional imaging, and leading to a new disease state: PSMA-avid/CT-negative metastatic ... Full text CiteAdditive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.
Journal Article Clin Cancer Res · December 4, 2025 BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown limited efficacy in unselected patients with metastatic castration-resistant prostate cancer (mCRPC). However, ICIs are approved for biomarker-defined subsets: microsatellite instability-high (MSI- ... Full text Link to item CiteComplete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma.
Journal Article Oncologist · December 1, 2025 Overexpression of human epidermal growth factor receptor 2 (HER2) has been implicated as a molecular driver of numerous solid tumor subtypes. An antibody drug conjugate (ADC) directed to HER2, trastuzumab-deruxtecan, recently gained tumor-agnostic FDA appr ... Full text Link to item CiteRecent Grants
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
Clinical TrialSignificant Contributor · Awarded by National Institutes of Health · 2014 - 2023Predicting patient-specific responses to personalize androgen deprivation therapy for prostate cancer
ResearchPrincipal Investigator · Awarded by H. Lee Moffitt Cancer Center & Research Institute · 2019 - 2022Conditional lethality of copper and disulfiram as a therapeutic modality for prostate cancer
ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2016 - 2022View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2019
M.H.S.
Harvard Medical School ·
2009
M.D.